Skip to main content
Equibles

SILVERCREST ASSET MANAGEMENT GROUP LLC

Position in NUVB — Nuvation Bio Inc.

CIK 1232395 NEW YORK, NY
Back to NUVB Full portfolio

Position in NUVB

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$5,802,267
+$2,694,664 QoQ
Shares Held
1,021,526
+41.0% QoQ
Ownership
0.291%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#38
of 242 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 66% Shared 0% None 34%

Common Shares in NUVB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SILVERCREST ASSET MANAGEMENT GROUP LLC holds $148,664,897 across 21 Biotechnology names. NUVB ranks #13 (3.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VCEL
Vericel Corp
 896,651 $39,892,002
2 TWST
Twist Bioscience Corp
 196,496 $20,215,508
3 MIRM
Mirum Pharmaceuticals, Inc.
 77,278 $9,046,935
4 ARWR
Arrowhead Pharmaceuticals, Inc.
 103,616 $8,445,740
5 MDGL
Madrigal Pharmaceuticals, Inc.
 15,655 $8,405,952
6 RYTM
Rhythm Pharmaceuticals, Inc.
 73,432 $8,153,154
7 VRTX
Vertex Pharmaceuticals Inc / Ma
 16,346 $8,119,548
8 COGT
Cogent Biosciences, Inc.
 159,545 $6,174,391

All Filings in NUVB

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,802,267 1,021,526
2026-03-31 $3,107,603 724,383